John Armitage
Egerton Capital
Egerton Capital Portfolio 13F
John Armitage Holdings Activity
- Portfolio value:
- $13.66B≈ (-$495M≈)
- Previous value:
- $14.16B≈
- # of changes:
- 34
- New positions:
- 8
- Reported for:
- 30 Jun 2019 (Q2)
- Latest filing date:
- 03 Aug 2022
Egerton Capital has disclosed a total of 34 changes to the portfolio in the (2019 Q2) SEC report(s): increased the number of shares of 7, bought 8 totally new, decreased the number of shares of 16 and completely sold out 3 position(s).
What stocks did John Armitage buy in 2019 Q2?
During 2019 Q2 John Armitage has bought 15 securities out of which top 5 purchases (by % change to portfolio) were (CHTR) Charter Communications Inc (added shares +1.50%), (CP) Canadian Pacific Kansas City Limited (added shares +14.15%), (BABA) Alibaba Group Holding Ltd (added shares +79.02%), (TIF) Tiffany & Co (added shares +53.29%) and (ADSK) Autodesk Inc (added shares +21.72%).
What did John Armitage invest in during 2019 Q2?
In the 2019 Q2 report(s) the following changes have been made to the top investments: (CHTR) Charter Communications Inc (added shares +1.50%), (UNP) Union Pacific Corp (reduced shares -22.28%), (AXP) American Express Company (reduced shares -13.96%), (CP) Canadian Pacific Kansas City Limited (added shares +14.15%) and (MSFT) Microsoft Corp (reduced shares -35.58%).
34 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Optimum Communications, Inc
|
new
|
$24.35
|
-96.64%($0.82)
|
0.70%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
Avantor Inc
|
new
|
$19.09
|
-39.44%($11.56)
|
0.61%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
DR Horton Inc
|
new
|
$43.13
|
+237.17%($145.42)
|
2.84%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
Equifax Inc
|
new
|
$135.24
|
+27.51%($172.44)
|
0.76%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
Meta Platforms Inc
|
new
|
$193.00
|
+211.87%($601.91)
|
2.44%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
IQVIA Holdings Inc
|
new
|
$160.90
|
+30.19%($209.48)
|
1.64%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
Thermo Fisher Scientific Inc
|
new
|
$293.68
|
+91.83%($563.38)
|
0.73%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
Transdigm Group Incorporated
|
new
|
$483.80
|
+155.64%($1,236.78)
|
1.41%
|
2019 Q2
|
≈ 0.25 years
|
||||
|
|
Alibaba Group Holding Ltd
|
+79.02%
|
$169.45
|
-33.49%($112.70)
|
6.00%
|
2017 Q3
|
≈ 2.00 years
|
||||
|
|
Tiffany & Co
|
+53.29%
|
$93.64
|
|
3.26%
|
2019 Q1
|
≈ 0.50 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.